CN

Company news

Location：

Home

/

Position

/

Job posting

Categories:Position
Author:
Origin:
Time of issue:2021-04-07
Views:0

Job posting

(Summary description)Nanjing REGENECORE Biotechnology Co., Ltd. was established in the National Biomedical Valley of Nanjing Jiangbei High-tech Zone. It has a scientific research and office base of nearly 5000 square meters. It is one of the first R&D institutions in the field of nanobodies in China.

Categories:Position
Author:
Origin:
Time of issue:2021-04-07
Views:0

Information

1

Scan the QR code to read on your phone

Previous: None

Next: None

Previous: None

Next: None

09-19

2024



Lv Xiangyang Visited Nanjing Regenecore and Thoth Institutes

Lv Xiangyang visited Nanjing Regenecore & Thoth Institutes, assessing developments & future development direction.

09-13

2024



Research bulletin: structural elucidation of a bispecific nanobody targeting IL-4Rα/IL-5

Regenecore used own nanobody platform to screen and construct bispecific nanobodies targeting IL-4Rα and IL-5.

09-12

2024



Nanjing Regenecore RT2831 project was approved by the State Food and Drug Administration for clinical trials

Regenecore will soon carry out clinical research on RT2831 project in China.

TEL：

025-58608860

Address: Room 07 Building 16 Treehouse, No. 73, Tanmi Road, Jiangbei New District, Nanjing

Enterprise email：rjk@regenecore.com

WeChat cooperative consultation

www.300.cn nanjing 备案号：ICP18030131-1

please try again.